Egyptian Drug Authority — May 2026

Against a manufacturer EDA has named

Another authority acted this month against a company EDA has itself recorded an action against at some point. That makes it worth EDA seeing. It does not make the foreign action EDA’s to answer for, and it is not an allegation about the company — each entry links to the issuing authority’s own notice.

• GE HealthCare, Ireland — Pharmacy and Poisons Board (KE), 2026-05-07: Omnipaque 350mg
  EDA has 1 recorded action(s) naming this manufacturer: DEA-EG-2026-0025
  Every recorded action naming this manufacturer

Our failures on EDA’s coverage, across the whole register rather than this month. Published because a report that told an authority only what it was missing would be an audit sent by someone with no standing to conduct one.

• 336 record(s) held from EDA in total
• 5 carry no publication date we could read
• 43 name neither a batch nor a stated reason
• 247 name no manufacturer
• 5 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
• 0 have no archived copy of the original notice

Each of these is something EDA published and this register did not capture, or captured incompletely. None of them is a failure by EDA.

Anything on this page that is wrong about Egyptian Drug Authority can be corrected by Egyptian Drug Authority, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.

Write to notices@drugeyeafrica.org. Corrections to existing records are logged and published on the corrections page; a superseded record keeps its URL and points forward to the one that replaced it.